Macular Degeneration Unknown Status Phase 2 Trials for Ranibizumab (DB01270)
Also known as: Macula lutea degeneration / Retinal macula lutea degeneration / Macular luteal degeneration / Degenerative disorder of macula (disorder) / Degeneration macular
| Indication | Status | Phase |
|---|---|---|
| DBCOND0027875 (Macular Degeneration) | Unknown Status | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02067013 | Analysis of Aqueous and Vitreous Humor | Basic Science |